Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Biaryl Alcohol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112481226B details solvent-tolerant ADH mutants for scalable production of chiral alcohols, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN108359649A reveals high-selectivity alcohol dehydrogenase mutants for synthesizing chiral biaryl alcohols, offering cost reduction and supply reliability.
Patent CN111094557B details novel ADH mutants enabling cost-effective, high-ee biocatalytic synthesis of chiral biaryl alcohols for antihistamine drugs.